Skip to main content

The Future of Digital Pathology and AI

Catarina Eloy, MD, PhD
Junya Fukuoka, Chair, Professor, Department of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences
Anil Parwani, MD, PhD, MBA

Leaders of the digital pathology associations in Europe (ESDIP), United States (DPA) and Japan (JSDP) have joined forces to accelerate the adoption of digital pathology.

Hosted by Colin White, Leica Biosystems’ SVP and General Manager, Advanced Staining & Imaging, three expert pathologists and leaders of their respective societies share their thoughts as to how this alliance aims to boost the exchange of knowledge across borders, unify concepts and standardization, and help break down political, social, and economic barriers.

If you have viewed this educational webinar, training or tutorial on Knowledge Pathway and would like to apply for continuing education credits with your certifying organization, please download the form to assist you in adding self-reported educational credits to your transcript.
Get Knowledge Pathway updates delivered directly to your inbox.

Learning Objectives

  • Learn about the Global Task Force and how you can get involved.
  • Discover how the exchange of knowledge across borders, unified concepts and standardization will accelerate the adoption of digital pathology.
  • Learn how to break down political, social, and economic barriers, including things as basic as mistrust in digital pathology.
  • Understand the panel's perspective on future technologies like AI.
     

Leica Biosystems Knowledge Pathway content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.

For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted.

Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.

About the presenters

Catarina Eloy, MD, PhD

Dr. Catarina Eloy is the Head of the Pathology Laboratory of IPATIMUP/ Researcher at i3S/ Affiliated Professor of Medical Faculty of The University of Porto. She is also the former President of the European Society for Digital and Integrative Pathology and Vice-president of the Portuguese Society of Anatomic Pathology.

Dr. Eloy received her MD in 2003 from the Medical Faculty of The University of Porto with a specialization in Pathology

Dr. Eloy has been a researcher since 2006 at the cancer signaling & metabolism of i3S/Ipatimup and received a Ph.D. in Thyroid cancer in 2012 by the Medical Faculty of The University of Porto.

Dr. Eloy has 70 publications and three academic and scientific awards/distinctions.

Junya Fukuoka, Chair, Professor, Department of Pathology Informatics, Nagasaki University Graduate School of Biomedical Sciences

Prof. Jun Fukuoka is a Japanese pathologist whose expertise lies in the field of pulmonary disease and digital pathology. He has graduated from Shiga University of Medical Science in 1995 and studied lung pathology and molecular research at Mayo Clinic, AFIP, and NIH.

He was promoted to full professor in 2009 in Toyama University and relocated as a department chair and professor at Nagasaki University in 2012. From 2017, he started cross-appointment with one of the largest hospitals, Kameda Medical Center, Department of Pathology, in Japan. He allocates 60% of his time at Nagasaki University and 40% at Kameda Medical Center.

He has launched two start-up companies during his career in the field of pathology. He is also a good teacher and has developed more than 30 pathologists worldwide and has mentored more than 100 undergraduate students/residents on either presenting research works in international meetings or publishing in scientific journals.

He has started research in digital pathology since 2010 and has developed a fully digitized network to share diagnostic process and education among several large institutes. Through the network, virtual large laboratory among several institutes has been created. His young team is enthusiastic to develop the workflow of human-AI collaboration.

He currently serves as Vice-President at Japanese Society of Digital Pathology (JSDP) and Treasurer of Digital Pathology Association (DPA).

Anil Parwani, MD, PhD, MBA

Dr. Anil Parwani is a Professor of Pathology at The Ohio State University. He serves as the Vice Chair and Director of Anatomical Pathology. Dr. Parwani is also the Director of Pathology Informatics and Director of the Digital Pathology Shared Resource at The James Cancer Hospital.

His research is focused on diagnostic and prognostic markers in bladder and prostate cancer, and molecular classification of renal cell carcinoma. Dr. Parwani has expertise in the area of Anatomical Pathology Informatics including designing quality assurance tools, bio banking informatics, clinical and research data integration, applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation.

Dr. Parwani has authored over 250 peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and one of the Editors of the Journal of Pathology Informatics.

Colin White is an IVD industry veteran with more than 20 years of experience in conceiving, developing and commercializing systems that advance the practice of pathology.

Colin is currently the Senior Vice President and General Manager, Advanced Staining & Imaging at Leica Biosystems, a position he has held since 2015. Colin’s passion is innovation and motivating teams to develop solutions that advance patient care whilst also meeting the needs of healthcare providers and regulating bodies.

Early in his career, Colin spent about a decade with BHP, a global resources company. Colin has a PhD and bachelor’s degree in chemical engineering from Monash University in Melbourne, Australia.

Want us to feature your writing?
We are looking for more great writers to feature here. Send us a submission and we’ll be in touch!
Like what you see?
Get more Knowledge Pathway content delivered directly to your inbox. Unsubscribe at any time.